Jin-Yu Ge

发表

Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial

Keda Yu, Z. Shao, Xi-Yu Liu, 2021, Journal of the National Cancer Institute.

Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis

Keda Yu, Z. Shao, Jin-Yu Ge, 2022, Nature communications.

The advance of adjuvant treatment for triple-negative breast cancer

Keda Yu, Z. Shao, Jin-Yu Ge, 2021, Cancer biology & medicine.

Immune-Activated Regional Lymph Nodes Predict Favorable Survival in Early-Stage Triple-Negative Breast Cancer

D. Ma, Jin-Yu Ge, Kexin Yu, 2020, Frontiers in Oncology.

Combined Single‐Cell and Spatial Transcriptomics Reveal the Metabolic Evolvement of Breast Cancer during Early Dissemination

Keda Yu, Z. Shao, Tong Liu, 2023, Advanced science.

Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis

Keda Yu, Z. Shao, Jin-Yu Ge, 2022, Nature Communications.

Multiomics of HER2-low triple-negative breast cancer identifies a receptor tyrosine kinase–relevant subgroup with therapeutic prospects

Keda Yu, D. Ma, Jin-Yu Ge, 2023, JCI insight.

Artificial intelligence-based diagnosis of breast cancer by mammography microcalcification

Yan Huang, Keda Yu, Z. Shao, 2023, Fundamental Research.

HER2 overexpression in ductal carcinoma in situ is associated with ipsilateral breast cancer recurrence after conservative surgery

K. Ding, Jin-Yu Ge, Kexin Yu, 2020, Translational cancer research.